APA (7th ed.) Citation

V, S., V, T., E, S., R, R., N, B., M, O., & B, M. (2021). Microbial Genomics as a Catalyst for Targeted Antivirulence Therapeutics. Frontiers in medicine, 8, 641260. https://doi.org/10.3389/fmed.2021.641260

Chicago Style (17th ed.) Citation

V, Sintchenko, Timms V, Sim E, Rockett R, Bachmann N, O'Sullivan M, and Marais B. "Microbial Genomics as a Catalyst for Targeted Antivirulence Therapeutics." Frontiers in Medicine 8 (2021): 641260. https://doi.org/10.3389/fmed.2021.641260.

MLA (9th ed.) Citation

V, Sintchenko, et al. "Microbial Genomics as a Catalyst for Targeted Antivirulence Therapeutics." Frontiers in Medicine, vol. 8, 2021, p. 641260, https://doi.org/10.3389/fmed.2021.641260.